PMC:7796052 / 10381-10647 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"290","span":{"begin":187,"end":197},"obj":"Gene"},{"id":"293","span":{"begin":80,"end":84},"obj":"Species"},{"id":"295","span":{"begin":98,"end":108},"obj":"Chemical"}],"attributes":[{"id":"A290","pred":"tao:has_database_id","subj":"290","obj":"Gene:3827"},{"id":"A293","pred":"tao:has_database_id","subj":"293","obj":"Tax:10116"},{"id":"A295","pred":"tao:has_database_id","subj":"295","obj":"MESH:D020849"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Thus, in a study aimed at assessing the vasoprotective effects of the compound, rats treated with raloxifene showed an increased reduction of systolic blood pressure on administration of bradykinin, suggesting an enhanced bioavailability of NO in these animals [37]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T67","span":{"begin":0,"end":266},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Thus, in a study aimed at assessing the vasoprotective effects of the compound, rats treated with raloxifene showed an increased reduction of systolic blood pressure on administration of bradykinin, suggesting an enhanced bioavailability of NO in these animals [37]."}